ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag conjugates disease medicine

bacteria and DNA molecules on a purple background.
Engineering the Microbiome: CRISPR Leads the Way
Mariella Bodemeier Loayza Careaga, PhD | Mar 15, 2024 | 10+ min read
Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.
Eat Yourself to Live: Autophagy’s Role in Health and Disease
Vikramjit Lahiri and Daniel J. Klionsky | Mar 1, 2018 | 10+ min read
New details of the molecular process by which our cells consume themselves point to therapeutic potential.
The Proteasome: A Powerful Target for Manipulating Protein Levels
John Hines and Craig M. Crews | May 1, 2017 | 10+ min read
The proteasome’s ability to target and degrade specific proteins is proving useful to researchers studying protein function or developing treatments for diseases.
New Immunoassay Products Let Users Put New Twists On Old Themes
Lisa Seachrist | Sep 29, 1996 | 8 min read
Advanced Chemtech AFfinity Bioreagents Biodesign International Bio-Rad Laboratories BioSource International Boehringer Mannheim Biochemicals Cardinal Associates Inc. Immunochemistry Technologies Peninsula Laboratories Inc. Tropix Inc. Wako Chemicals USA Inc. Wallac Inc. A quick inventory of nearly any molecular biology laboratory these days will turn up a kudzu-like infestation of monoclonal antibodies, fluorescent-tagged secondary antibodies, and immunoassay kits. Immunoassays have become de
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
2018 Top 10 Innovations
The Scientist | Dec 1, 2018 | 10+ min read
Biology happens on many levels, from ecosystems to electron transport chains. These tools may help spur discoveries at all of life's scales.
Variations on a Gene
Amy Francis | Jul 23, 2000 | 10+ min read
Photodisc Although President Bill Clinton surely had something in mind during his 2000 State of the Union address when he asked the nation to "celebrate our diversity," insights into human diversity at the molecular level are promising to speed drug discovery and revolutionize medicine to mark- edly improve human health. Individuals differ at one in 1,000 base pairs, which adds up to a whopping number of human genetic variations when applied to the roughly three billion base pairs of the human g
Picturing Infection
Kelly Rae Chi | Jan 1, 2015 | 7 min read
Whole-animal, light-based imaging of infected small mammals
A Sharper Image
Bob Sinclair | Apr 29, 2001 | 10+ min read
Medical miracles abound, yet cancer continues to be a complex and challenging problem. "Cancer" is actually a generic, catchall term for the malignant tumors that are found in well over a hundred different diseases, but the basic concept is simple enough--a gene goes wrong and a tumor grows. Unfortunately, the reality is more complicated, involving an intricate sequence of phenomena and interactions in just a handful of the body's tens-of-trillions of cells. And therein lies the problem for rese
Recourse to Death
Michael Brush | Aug 20, 2000 | 10 min read
Manufactureres of Flow Cytometry Products for Apoptosis Detection To examine the causes of life, we must first have recourse to death," uttered Victor Frankenstein upon beginning his search for the source from "whence the principle of life proceeds" and ultimately creating his nameless monster. Frankenstein's real creator, 19-year-old Mary Shelley, probably had no idea when Frankenstein was first published in 1816 that her main character's motivation would eventually have real-life implication

Run a Search

ADVERTISEMENT